A detailed history of Abound Wealth Management transactions in Viatris Inc stock. As of the latest transaction made, Abound Wealth Management holds 56 shares of VTRS stock, worth $738. This represents 0.0% of its overall portfolio holdings.

Number of Shares
56
Previous 56 -0.0%
Holding current value
$738
Previous $596,000 9.23%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2024

SELL
$9.02 - $10.29 $144 - $164
-16 Reduced 22.22%
56 $559,000
Q1 2023

Aug 07, 2024

BUY
$9.2 - $12.26 $662 - $882
72 New
72 $693,000
Q3 2022

Aug 07, 2024

SELL
$8.48 - $11.13 $135 - $178
-16 Reduced 22.22%
56 $478,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $16B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.